L3Harris Technologies, Inc. (NYSE: LHX) announced the immediate resignation of Chairman and Chief Executive Officer Christopher Kubasik on August 17, 2026, citing conduct inconsistent with its Code of Conduct.

The disclosure triggered a sharp market reaction. L3Harris shares fell $13.44 per share, or 4.61%, to close at $278.38 per share on August 17, 2026.

Legal Investigation Underway

Pomerantz LLP has initiated an investigation into potential securities fraud or other unlawful business practices by L3Harris and certain officers or directors. The firm is seeking investors who purchased stock during the relevant period to evaluate claims on behalf of a potential class action.

Key Details

• Resignation Date: Effective immediately as of August 17, 2026.
• Reason: Conduct not consistent with company values per Code of Conduct.
• Stock Impact: Down 4.61% to $278.38 per share.
• Legal Action: Pomerantz LLP investigating securities fraud claims.

What the Numbers Show

The immediate 4.61% decline in share price following the CEO's departure suggests the market views the leadership change and associated conduct issues as a material negative event. The simultaneous launch of a securities fraud investigation adds regulatory uncertainty, potentially impacting investor confidence beyond the initial valuation adjustment reflected in the single-day drop.

Contact Information

Investors with questions regarding the investigation are advised to contact Danielle Peyton at Pomerantz LLP via email at newaction@pomlaw.com or by phone at 646-581-9980, ext. 7980.

L3Harris Technologies (NYSE: LHX) shares traded lower on Monday, falling 3.84% to $280.62, following an executive leadership overhaul and new reports regarding the circumstances of the previous CEO's departure. The defense contractor appointed Sam Mehta as president and chief executive officer, effective immediately, succeeding Christopher Kubasik, who stepped down from his roles as chairman, CEO, and board member.

The transition follows an investigation into conduct by Kubasik that violated the company’s Code of Conduct. Independent counsel assisted in the review, and the company stated the conduct was unrelated to financial reporting, controls, customer relationships, or operational performance. However, a Wall Street Journal exclusive reported that women at L3Harris shared concerns about Kubasik’s behavior years before his ouster.

Legal Investigations Launched

Pomerantz LLP announced on August 27, 2026, that it is investigating claims on behalf of investors of L3Harris Technologies. The firm is examining whether L3Harris and certain officers or directors engaged in securities fraud or other unlawful business practices.

Separately, Schall, Brown & Schwartz LLP announced it is also investigating claims on behalf of investors for violations of securities laws. This firm is examining whether the company issued false or misleading statements or failed to disclose pertinent information.

The investigations stem from the August 17, 2026 disclosure that Christopher Kubasik stepped down as Chairman and Chief Executive Officer. On that news, LHX stock fell $13.44 per share, or 4.61%, to close at $278.38 per share.

Leadership Changes

Alongside the CEO appointment, Lewis Hay III, previously the Lead Independent Director, assumed the role of Independent Chairman. Mehta also joins the Board of Directors in his new executive capacity.

Additional leadership appointments include:

• Lauren Barnes as president of Space & Mission Systems
• Christopher Aebli as president of Communications and Spectrum Dominance

Financial Outlook Reaffirmed

Despite the leadership changes, L3Harris reaffirmed its full-year 2026 financial guidance. The company maintains a sales outlook of $23.200 billion to $23.700 billion for FY26. This range aligns closely with the analyst estimate of $23.579 billion.

Technical Analysis

LHX is trading below key moving averages, reflecting a bearish longer-term bias. The stock sits 2.3% below its 20-day SMA ($288.60) and 10.8% below its 200-day SMA ($315.92). A Death Cross formed in June, with the 20-day SMA below the 50-day SMA, which is below the 200-day SMA.

Key resistance lies at $304.50, near a prior pivot zone and the 100-day EMA area. Support is located at $270.50, close to the lower end of the recent range and above the 52-week low zone.